Founded in Frederick in 2004, BioFactura develops and manufactures biosimilars, biodefense medical countermeasures, and other biologic medicines using its patented StableFast biomanufacturing platform. The clinical-stage company has advanced programs for a smallpox therapeutic and a proposed ustekinumab biosimilar, while its Capitol Biologics division provides development and early-phase clinical manufacturing support to emerging biotech firms and government agencies.
Quality Management System (QMS)
compliance_program
Facility Monitoring System (FMS)
compliance_program
FDA, EMA, and ICH-aligned quality system
compliance_program
Emergent BioSolutionsFounded in 1998 to supply the U.S. government with anthrax vaccine, Emergent BioSolutions develops and manufactures medical countermeasures and other protective products for biological threats and opioid overdose emergencies. The company also operates as a strategic manufacturing partner, using specialized containment capabilities across four North American facilities to help biopharma companies, governments and nonprofits develop and make complex biological products. Its commercial portfolio includes NARCAN® Nasal Spray alongside preparedness products for threats such as anthrax, smallpox and botulism.ROCKVILLE, MD
Emergent BioSolutionsFounded in 1998 through a U.S. government partnership to supply an anthrax vaccine, Emergent BioSolutions develops, manufactures and delivers medical countermeasures and other life-saving products for biological threats and opioid overdose emergencies. The company also operates as a strategic manufacturing partner, using specialized containment and manufacturing capabilities across four North American facilities to support biopharma innovators, governments and nonprofits. Its portfolio includes the public-health products BioThrax and NARCAN Nasal Spray, and Emergent has worked in health-threat preparedness for more than 25 years.325412PLYMOUTH MEETING, PA
Emergent BioSolutionsFounded in 1998 through a partnership with the U.S. government to supply an anthrax vaccine, Emergent BioSolutions develops, manufactures and delivers medical countermeasures and other protective products for public-health emergencies. The company has spent more than 25 years preparing governments and communities for biological threats, while also expanding access to naloxone for opioid-overdose response. Emergent also operates four North American manufacturing facilities and partners with biopharma innovators on complex development and manufacturing work.GAITHERSBURG, MD
IDT BiologikaFounded in 1921, IDT Biologika is a Dessau-Rosslau-based global CDMO that develops and manufactures vaccines, viral vectors, biologics and sterile injectables from early development through commercial supply. Its particular strength is more than a century of experience working with live viruses, supported by BSL-2 facilities, integrated process development and manufacturing, and in-house quality and analytical services. Now part of SK bioscience, the company employs about 1,600 people and serves pharmaceutical and biotechnology customers as well as governments worldwide.ROCKVILLE, MD